On the recordApril 29, 2015
It would foster research to increase the number of safe, effective, and affordable rare disease medicines.
Source
congress.govEditor's note · Context
Bilirakis explains the purpose of the Open Act for rare disease treatments.
Share & report
More from Gus Bilirakis
Sep 23, 2024
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of my bill, H.R. 7189, the Congenital Heart Futures Reauthorization Act of 2024, and I urge my colleagues to support this particular bill. This…
Apr 28, 2025
Mr. Speaker, I yield such time as she may consume to the gentlewoman from Florida (Ms. Salazar), the House sponsor of this particular bill, who is my good friend and a very effective Member of Congress.
Apr 28, 2025
Mr. Speaker, I appreciate the remarks of the gentlewoman from Illinois. I just want to say it has been great working with Representative Schakowsky on a number of bills over the years. She has really been very cooperative, and we are doing…
Apr 28, 2025
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 2399) to require the Federal Communications Commission to establish a vetting process for prospective applicants for high-cost universal service program funding. The Clerk…
Other voices in this conversation
